Morolimumab
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | RhD |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
![]() ![]() |
Morolimumab is a human monoclonal antibody against the human Rhesus factor.[1]
References[edit]
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
|
![]() | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
![]() | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- All stub articles